Tower Research Capital LLC (Trc) Aadi Bioscience, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,793 shares of AADI stock, worth $5,379. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,793
Previous 13,668
86.88%
Holding current value
$5,379
Previous $19,000
84.21%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AADI
# of Institutions
55Shares Held
12.6MCall Options Held
23.8KPut Options Held
0-
Avoro Capital Advisors LLC New York, NY2.85MShares$8.55 Million0.09% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2MShares$6 Million2.42% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$5.55 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.85MShares$5.54 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA766KShares$2.3 Million0.0% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $63.1M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...